agilon health Inc (AGL)
Aktien-Chart
Loading...
•
Kauf
•
Verkauf
•
Geplanter Kauf
•
Geplanter Verkauf
Netto-Kauf
Netto-Verkauf
Earnings
Earnings
Value bought
Letzte 90 Tage
Value sold
Letzte 90 Tage
Net insiders buying
Letzte 90 Tage
Trades (buy and sell)
Letzte 90 Tage
Abkürzungen K: Kauf, V: Verkauf, GK: Geplanter Kauf, GV: Geplanter Verkauf, S: Sonstiges
| Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion | Insider und/oder position |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Wert | Details |
|---|---|---|---|---|---|---|---|---|
| 2024-12-13 | 2024-12-13 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied |
25.000
+51.9%
2,2055.085 USD |
25.000 +51.9% | 2,20 | 55.085 USD | |
| 2024-12-13 | 2024-12-11 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied |
25.062
+61.0%
2,0150.269 USD |
25.062 +61.0% | 2,01 | 50.269 USD | |
| 2024-12-11 | 2024-12-09 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied |
7.500
+14.6%
2,2016.489 USD |
7.500 +14.6% | 2,20 | 16.489 USD | |
| 2024-12-11 | 2024-12-05 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied |
45.000
+27.9%
2,1898.145 USD |
45.000 +27.9% | 2,18 | 98.145 USD | |
| 2024-12-11 | 2024-11-25 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied |
12.500
+32.2%
2,2828.474 USD |
12.500 +32.2% | 2,28 | 28.474 USD | |
| 2024-09-16 | 2024-09-12 | K Kauf |
CEO & President Geschäftsführender Verwaltungsratsmitglied |
20.000
+42.0%
3,3667.188 USD |
20.000 +42.0% | 3,36 | 67.188 USD | |
| 2024-03-18 | 2024-03-14 | K Kauf |
Chief Technology Officer Führungsperson |
5.434
0,000 USD |
5.434 | 0,00 | 0 USD | |
| 2024-03-18 | 2024-03-14 | K Kauf |
Chief Financial Officer Führungsperson |
14.945
0,000 USD |
14.945 | 0,00 | 0 USD | |
| 2024-03-18 | 2024-03-14 | K Kauf |
Chief Markets Officer Führungsperson |
274.455
0,000 USD |
274.455 | 0,00 | 0 USD | |
| 2024-03-18 | 2024-03-14 | K Kauf |
Chief Med. & Quality Officer Führungsperson |
5.434
0,000 USD |
5.434 | 0,00 | 0 USD | |
| 2024-03-18 | 2024-03-14 | K Kauf |
Chief Strategy & Dev. Officer Führungsperson |
11.956
0,000 USD |
11.956 | 0,00 | 0 USD | |
| 2023-11-30 | 2023-11-29 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied |
22.300
+231.5%
11,22250.206 USD |
22.300 +231.5% | 11,22 | 250.206 USD | |
| 2023-11-21 | 2023-11-21 | K Kauf |
CEO & President Geschäftsführender Verwaltungsratsmitglied |
44.690
+1541.0%
11,14497.739 USD |
44.690 +1541.0% | 11,14 | 497.739 USD | |
| 2023-09-14 | 2023-09-13 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
18.750
-19.1%
18,00337.455 USD |
18.750 -19.1% | 18,00 | 337.455 USD | |
| 2023-09-14 | 2023-09-12 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
18.750
-19.1%
18,05338.481 USD |
18.750 -19.1% | 18,05 | 338.481 USD | |
| 2023-09-13 | 2023-09-11 | V Verkauf |
Chief Accounting Officer Führungsperson |
8.750
-33.8%
18,61162.838 USD |
8.750 -33.8% | 18,61 | 162.838 USD | |
| 2023-09-13 | 2023-09-11 | V Verkauf |
Chief Accounting Officer Führungsperson |
17.500
-50.5%
18,62325.778 USD |
17.500 -50.5% | 18,62 | 325.778 USD | |
| 2023-08-16 | 2023-08-15 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
18.750
-19.1%
18,10339.309 USD |
18.750 -19.1% | 18,10 | 339.309 USD | |
| 2023-08-16 | 2023-08-14 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
18.750
-19.1%
18,72351.083 USD |
18.750 -19.1% | 18,72 | 351.083 USD | |
| 2023-07-14 | 2023-07-13 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
18.750
-19.1%
16,93317.424 USD |
18.750 -19.1% | 16,93 | 317.424 USD | |
| 2023-07-14 | 2023-07-12 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
18.750
-19.1%
16,97318.182 USD |
18.750 -19.1% | 16,97 | 318.182 USD | |
| 2023-06-16 | 2023-06-15 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
18.750
-19.1%
18,73351.103 USD |
18.750 -19.1% | 18,73 | 351.103 USD | |
| 2023-06-16 | 2023-06-14 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
1.100
-1.4%
19,1721.084 USD |
1.100 -1.4% | 19,17 | 21.084 USD | |
| 2023-06-16 | 2023-06-14 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
15.799
-16.6%
18,60293.868 USD |
15.799 -16.6% | 18,60 | 293.868 USD | |
| 2023-06-16 | 2023-06-14 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
1.851
-2.3%
17,9333.194 USD |
1.851 -2.3% | 17,93 | 33.194 USD | |
| 2023-05-18 | 2023-05-18 | V Verkauf |
CD&R Investment Associates IX, Ltd. Large shareholder |
94.173.804
-48.5%
20,801.958.937.549 USD |
94.173.804 -48.5% | 20,80 | 1.958.937.549 USD | |
| 2023-05-17 | 2023-05-16 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
25.000
-23.9%
23,14578.535 USD |
25.000 -23.9% | 23,14 | 578.535 USD | |
| 2023-05-17 | 2023-05-15 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
25.000
-23.9%
23,79594.733 USD |
25.000 -23.9% | 23,79 | 594.733 USD | |
| 2023-05-11 | 2023-05-09 | GV Geplanter Verkauf |
Chief Strategy & Dev. Officer Führungsperson |
4.500
-1.5%
26,15117.666 USD |
4.500 -1.5% | 26,15 | 117.666 USD | |
| 2023-04-21 | 2023-04-20 | GV Geplanter Verkauf |
Chief Strategy & Dev. Officer Führungsperson |
500
-0.2%
26,1513.074 USD |
500 -0.2% | 26,15 | 13.074 USD | |
| 2023-04-21 | 2023-04-19 | GV Geplanter Verkauf |
Chief Strategy & Dev. Officer Führungsperson |
455
-0.2%
27,8412.666 USD |
455 -0.2% | 27,84 | 12.666 USD | |
| 2023-04-21 | 2023-04-19 | GV Geplanter Verkauf |
Chief Strategy & Dev. Officer Führungsperson |
4.545
-1.5%
26,82121.877 USD |
4.545 -1.5% | 26,82 | 121.877 USD | |
| 2023-04-19 | 2023-04-18 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
25.000
-23.9%
28,05701.130 USD |
25.000 -23.9% | 28,05 | 701.130 USD | |
| 2023-04-19 | 2023-04-17 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
1.400
-1.7%
28,5439.957 USD |
1.400 -1.7% | 28,54 | 39.957 USD | |
| 2023-04-19 | 2023-04-17 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
23.600
-22.6%
27,70653.640 USD |
23.600 -22.6% | 27,70 | 653.640 USD | |
| 2023-03-27 | 2023-03-24 | GV Geplanter Verkauf |
Chief Strategy & Dev. Officer Führungsperson |
97.290
-26.0%
28,702.792.379 USD |
97.290 -26.0% | 28,70 | 2.792.379 USD | |
| 2023-03-27 | 2023-03-23 | GV Geplanter Verkauf |
Chief Strategy & Dev. Officer Führungsperson |
22.710
-7.6%
28,71651.911 USD |
22.710 -7.6% | 28,71 | 651.911 USD | |
| 2023-03-24 | 2023-03-23 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
8.094
-12.7%
28,04226.978 USD |
8.094 -12.7% | 28,04 | 226.978 USD | |
| 2023-03-24 | 2023-03-22 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
8.094
-12.7%
27,84225.376 USD |
8.094 -12.7% | 27,84 | 225.376 USD | |
| 2023-03-17 | 2023-03-16 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
10.581
-14.9%
26,08275.965 USD |
10.581 -14.9% | 26,08 | 275.965 USD | |
| 2023-03-17 | 2023-03-16 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
9.831
-12.1%
25,65252.192 USD |
9.831 -12.1% | 25,65 | 252.192 USD | |
| 2023-03-17 | 2023-03-16 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
4.588
-5.4%
24,36111.741 USD |
4.588 -5.4% | 24,36 | 111.741 USD | |
| 2023-03-17 | 2023-03-16 | GV Geplanter Verkauf |
Chief Strategy & Dev. Officer Führungsperson |
60.000
-17.8%
26,091.565.196 USD |
60.000 -17.8% | 26,09 | 1.565.196 USD | |
| 2023-03-17 | 2023-03-15 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
25.000
-29.2%
23,80595.075 USD |
25.000 -29.2% | 23,80 | 595.075 USD | |
| 2023-03-17 | 2023-03-15 | V Verkauf |
Chief Markets Officer Führungsperson |
35.000
-29.0%
23,81833.231 USD |
35.000 -29.0% | 23,81 | 833.231 USD | |
| 2023-03-17 | 2023-03-15 | V Verkauf | Nicht geschäftsführender Verwaltungsratsmitglied |
80.000
-39.3%
23,821.905.224 USD |
80.000 -39.3% | 23,82 | 1.905.224 USD | |
| 2023-03-17 | 2023-03-15 | V Verkauf |
Chief Med. & Quality Officer Führungsperson |
55.000
-49.8%
23,811.309.424 USD |
55.000 -49.8% | 23,81 | 1.309.424 USD | |
| 2023-03-09 | 2023-03-08 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
8.094
-43.7%
24,44197.821 USD |
8.094 -43.7% | 24,44 | 197.821 USD | |
| 2023-03-09 | 2023-03-07 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
8.094
-43.7%
24,36197.197 USD |
8.094 -43.7% | 24,36 | 197.197 USD | |
| 2023-02-16 | 2023-02-15 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
28.555
-52.7%
23,37667.342 USD |
28.555 -52.7% | 23,37 | 667.342 USD | |
| 2023-02-16 | 2023-02-15 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
8.094
-43.7%
22,98186.028 USD |
8.094 -43.7% | 22,98 | 186.028 USD | |
| 2023-02-16 | 2023-02-14 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
50.000
-66.1%
22,981.149.060 USD |
50.000 -66.1% | 22,98 | 1.149.060 USD | |
| 2023-02-16 | 2023-02-14 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
25.881
-71.3%
22,99594.877 USD |
25.881 -71.3% | 22,99 | 594.877 USD | |
| 2023-02-03 | 2023-02-02 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
30.782
-74.7%
22,99707.561 USD |
30.782 -74.7% | 22,99 | 707.561 USD | |
| 2023-02-03 | 2023-02-01 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
5.396
-34.1%
21,76117.420 USD |
5.396 -34.1% | 21,76 | 117.420 USD | |
| 2023-01-23 | 2023-01-20 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
5.396
-34.1%
19,92107.496 USD |
5.396 -34.1% | 19,92 | 107.496 USD | |
| 2023-01-23 | 2023-01-19 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
10.792
-50.9%
19,73212.943 USD |
10.792 -50.9% | 19,73 | 212.943 USD | |
| 2023-01-19 | 2023-01-18 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
20.723
-44.7%
19,78409.889 USD |
20.723 -44.7% | 19,78 | 409.889 USD | |
| 2023-01-19 | 2023-01-17 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
25.722
-50.1%
19,91512.225 USD |
25.722 -50.1% | 19,91 | 512.225 USD | |
| 2023-01-09 | 2023-01-06 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
2.698
-20.6%
15,4641.702 USD |
2.698 -20.6% | 15,46 | 41.702 USD | |
| 2023-01-09 | 2023-01-05 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
2.698
-20.6%
15,5141.845 USD |
2.698 -20.6% | 15,51 | 41.845 USD | |
| 2022-12-19 | 2022-12-16 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
5.398
-34.1%
16,8290.807 USD |
5.398 -34.1% | 16,82 | 90.807 USD | |
| 2022-12-19 | 2022-12-15 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
5.398
-34.1%
17,4294.013 USD |
5.398 -34.1% | 17,42 | 94.013 USD | |
| 2022-12-16 | 2022-12-15 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
18.750
-42.3%
17,26323.663 USD |
18.750 -42.3% | 17,26 | 323.663 USD | |
| 2022-12-16 | 2022-12-14 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
18.750
-42.3%
17,52328.491 USD |
18.750 -42.3% | 17,52 | 328.491 USD | |
| 2022-12-07 | 2022-12-06 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
5.398
-34.1%
17,7295.632 USD |
5.398 -34.1% | 17,72 | 95.632 USD | |
| 2022-12-07 | 2022-12-05 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
5.398
-34.1%
17,8096.079 USD |
5.398 -34.1% | 17,80 | 96.079 USD | |
| 2022-11-22 | 2022-11-18 | K Kauf |
CEO & President Geschäftsführender Verwaltungsratsmitglied |
2.900
+inf%
17,1449.705 USD |
2.900 +inf% | 17,14 | 49.705 USD | |
| 2022-11-18 | 2022-11-17 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
5.396
-34.1%
17,4394.055 USD |
5.396 -34.1% | 17,43 | 94.055 USD | |
| 2022-11-18 | 2022-11-17 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
18.750
-42.3%
17,17321.956 USD |
18.750 -42.3% | 17,17 | 321.956 USD | |
| 2022-11-18 | 2022-11-16 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
5.396
-34.1%
18,5299.919 USD |
5.396 -34.1% | 18,52 | 99.919 USD | |
| 2022-11-18 | 2022-11-16 | GV Geplanter Verkauf |
Chief Markets Officer Führungsperson |
18.750
-42.3%
18,29343.009 USD |
18.750 -42.3% | 18,29 | 343.009 USD | |
| 2022-11-03 | 2022-11-02 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
5.396
-34.1%
19,53105.407 USD |
5.396 -34.1% | 19,53 | 105.407 USD | |
| 2022-11-03 | 2022-11-01 | GV Geplanter Verkauf |
Chief Med. & Quality Officer Führungsperson |
5.396
-34.1%
20,03108.093 USD |
5.396 -34.1% | 20,03 | 108.093 USD | |
| 2022-10-21 | 2022-10-20 | V Verkauf |
Chief Markets Officer Führungsperson |
1.500
-5.5%
20,6630.991 USD |
1.500 -5.5% | 20,66 | 30.991 USD |